Correlation Between the Ki-67 Proliferation Index and Response to Radiation Therapy in Small Cell Lung Cancer

Overview

Journal Radiat Oncol

Publisher Biomed Central

Specialties Oncology
Radiology

Date 2017 Jan 15

PMID 28086989

Citations 35

Authors

Naoya Ishibashi

Toshiya Maebayashi

Takuya Aizawa

Masakuni Sakaguchi

Haruna Nishimaki

Shinobu Masuda

Affiliations

Soon will be listed here.

Abstract

Background: In the breast cancer, the decision whether to administer adjuvant therapy is increasingly influenced by the Ki-67 proliferation index. In the present retrospective study, we investigated if this index could predict the therapeutic response to radiation therapy in small cell lung cancer (SCLC).

Methods: Data from 19 SCLC patients who received thoracic radiation therapy were included. Clinical staging was assessed using the TNM classification system (UICC, 2009; cstage IIA/IIB/IIIA/IIIB = 3/1/7/8). Ki-67 was detected using immunostained tumour sections and the Ki-67 proliferation index was determined using e-Count software. Radiation therapy was administered at total doses of 45-60 Gy. A total of 16 of the 19 patients received chemotherapy.

Results: Patients were divided into two groups, one with a Ki-67 proliferation index ≥79.77% (group 1, 8 cases) and the other with a Ki-67 proliferation index <79.77% (group 2, 11 cases). Following radiation therapy, a complete response (CR) was observed in six cases from group 1 (75.0%) and three cases from group 2 (27.3%). The Ki-67 proliferation index was significantly correlated with the CR rate (P = 0.05), which was significantly higher in group 1 than in group 2 (P = 0.04). The median survival time was 516 days for all patients, and the survival rates did not differ significantly between groups 1 and 2.

Conclusions: Our study is the first to evaluate the correlation between the Ki-67 proliferation index and SCLC tumour response to radiation therapy. Our findings suggest that a high Ki-67 proliferation index might represent a predictive factor for increased tumour radiosensitivity.

Citing Articles

Bladder Cancer Treatments in the Age of Personalized Medicine: A Comprehensive Review of Potential Radiosensitivity Biomarkers.

Feghaly C, Challita R, Hadir H, Mobayed T, Bitar T, Harbi M Biomark Insights. 2024; 19:11772719241297168.

PMID: 39512649 PMC: 11542137. DOI: 10.1177/11772719241297168.

Effect of Ki-67 proliferation index on survival in large cell neuroendocrine carcinoma of the lung.

Duygulu M, Asik E, Tukenmez M, Teoman G, Yildirim A, Fidan E Rev Assoc Med Bras (1992). 2024; 70(9):e20240398.

PMID: 39292084 PMC: 11404992. DOI: 10.1590/1806-9282.20240398.

Morphological aspects of small intestinal mucosal injury and repair after electron irradiation.

Demyashkin G, Karakaeva E, Saakian S, Shchekin V, Elbuzdukaev E, Bamatgiraev U Anat Cell Biol. 2024; 57(3):384-391.

PMID: 38880781 PMC: 11424566. DOI: 10.5115/acb.24.050.

Predicting Neoadjuvant Treatment Response in Triple-Negative Breast Cancer Using Machine Learning.

Bhattarai S, Saini G, Li H, Seth G, Fisher T, Janssen E Diagnostics (Basel). 2024; 14(1).

PMID: 38201383 PMC: 10871101. DOI: 10.3390/diagnostics14010074.

Small Cell Oesophageal Carcinoma: A Retrospective Case Series From a UK Tertiary Centre and a Review of the Literature.

Zemerly S, Thurairajasingam K, Deeb B, Tilby M Cureus. 2023; 15(11):e49435.

PMID: 38149143 PMC: 10750842. DOI: 10.7759/cureus.49435.

References

Martin B, Paesmans M, Mascaux C, Berghmans T, Lothaire P, Meert A . Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Br J Cancer. 2004; 91(12):2018-25. PMC: 2409786. DOI: 10.1038/sj.bjc.6602233. View

Pelosi G, Rindi G, Travis W, Papotti M . Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice. J Thorac Oncol. 2014; 9(3):273-84. DOI: 10.1097/JTO.0000000000000092. View

Skov B, Holm B, Erreboe A, Skov T, Mellemgaard A . ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival. J Thorac Oncol. 2010; 5(4):453-9. DOI: 10.1097/JTO.0b013e3181ca063b. View

Valente G, Orecchia R, Gandolfo S, Arnaudo M, Ragona R, Kerim S . Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?. J Clin Pathol. 1994; 47(2):109-12. PMC: 501821. DOI: 10.1136/jcp.47.2.109. View

Gerdes J, Schwab U, Lemke H, STEIN H . Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983; 31(1):13-20. DOI: 10.1002/ijc.2910310104. View

Taillade L, Penault-Llorca F, Boulet T, Fouret P, Michiels S, Taranchon E . Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer. Ann Oncol. 2007; 18(6):1043-50. DOI: 10.1093/annonc/mdm072. View

Suzuki T, Sadahiro S, Fukasawa M, Ishikawa K, Kamijo A, Yasuda S . Predictive factors of tumor shrinkage and histological regression in patients who received preoperative radiotherapy for rectal cancer. Jpn J Clin Oncol. 2005; 34(12):740-6. DOI: 10.1093/jjco/hyh140. View

Roge R, Riber-Hansen R, Nielsen S, Vyberg M . Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining. Breast Cancer Res Treat. 2016; 158(1):11-19. DOI: 10.1007/s10549-016-3852-6. View

Niikura N, Sakatani T, Arima N, Ohi Y, Honma N, Kanomata N . Assessment of the Ki67 labeling index: a Japanese validation ring study. Breast Cancer. 2014; 23(1):92-100. DOI: 10.1007/s12282-014-0536-0. View

10.

de Azambuja E, Cardoso F, de Castro Jr G, Colozza M, Mano M, Durbecq V . Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer. 2007; 96(10):1504-13. PMC: 2359936. DOI: 10.1038/sj.bjc.6603756. View

11.

Dowsett M, Nielsen T, AHern R, Bartlett J, Coombes R, Cuzick J . Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst. 2011; 103(22):1656-64. PMC: 3216967. DOI: 10.1093/jnci/djr393. View

12.

Ciancio N, Galasso M, Campisi R, Bivona L, Migliore M, Di Maria G . Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer. Multidiscip Respir Med. 2012; 7(1):29. PMC: 3537558. DOI: 10.1186/2049-6958-7-29. View

13.

Goldhirsch A, Wood W, Coates A, Gelber R, Thurlimann B, Senn H . Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011; 22(8):1736-47. PMC: 3144634. DOI: 10.1093/annonc/mdr304. View

14.

Kayser G, Gunzenhauser I, Becker H, Herth F, Kayser K . [Proliferation rate of small cell lung carcinoma. A cytomorphometric parameter with prognostic significance]. Pathologe. 2001; 22(5):326-32. DOI: 10.1007/s002920100480. View

15.

Travis W, Brambilla E, Burke A, Marx A, Nicholson A . Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol. 2015; 10(9):1240-1242. DOI: 10.1097/JTO.0000000000000663. View

16.

Carney D, Mitchell J, Kinsella T . In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. Cancer Res. 1983; 43(6):2806-11. View

17.

Pelosi G, Rodriguez J, Viale G, Rosai J . Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol. 2005; 29(2):179-87. DOI: 10.1097/01.pas.0000149690.75462.29. View

18.

Kikuchi M, Mikami T, Sato T, Tokuyama W, Araki K, Watanabe M . High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction. Br J Cancer. 2009; 101(1):116-23. PMC: 2713712. DOI: 10.1038/sj.bjc.6605105. View

19.

De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, Kester A, Rutten I, Lambin P . Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol. 2005; 17(4):543-52. DOI: 10.1093/annonc/mdj094. View

20.

Nakano T, Oka K . Differential values of Ki-67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer. Cancer. 1993; 72(8):2401-8. DOI: 10.1002/1097-0142(19931015)72:8<2401::aid-cncr2820720818>3.0.co;2-d. View